Taran Therapeutics, Inc.
PrivateLast Round
Corporate Funding
Feb 20, 2024
Total Funding Raised
$2M
Company Overview
Taran Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing monoclonal antibody therapies for hematology, oncology, and inflammatory conditions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Taran Therapeutics, Inc. Comparables
Compare Taran Therapeutics, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Roivant Sciences | 80% | |
| Solu Therapeutics | 80% | |
| I-Mab Biopharma | 71% |
Taran Therapeutics, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Corporate Funding | Feb 20, 2024 |
Taran Therapeutics, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Taran Therapeutics, Inc.'s valuation, stock price, and market status.
Is Taran Therapeutics, Inc. a public or private company?
Taran Therapeutics, Inc. is a private company.
What is the current stock price of Taran Therapeutics, Inc.?
Taran Therapeutics, Inc. is a private company with no public stock price. No recent secondary market data is available.
How much is Taran Therapeutics, Inc. worth (valuation)?
Valuation information for Taran Therapeutics, Inc. is not publicly available.
Can I buy Taran Therapeutics, Inc. stock?
Taran Therapeutics, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Taran Therapeutics, Inc.'s last funding round?
Taran Therapeutics, Inc.'s most recent funding round was Corporate Funding on February 20, 2024.
Who are the main investors in Taran Therapeutics, Inc.?
Investor information for Taran Therapeutics, Inc. is not publicly disclosed.
Will Taran Therapeutics, Inc. IPO soon?
No public IPO plans have been announced for Taran Therapeutics, Inc..
How can I track Taran Therapeutics, Inc. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Taran Therapeutics, Inc.'s secondary market activity and sign up for updates.